Chiral compounds | 생성물

1821057-76-4

β-D-allo-Octofuranocytidine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-77-5

β-D-allo-Octofuranoadenosine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-78-6

β-D-allo-Octofuranoadenosine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-79-7

β-D-allo-Octofuranouridine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-5-methyl-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-80-0

β-D-allo-Octofuranouridine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-(2-methoxyethyl)-5-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-81-1

β-D-allo-Octofuranouridine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-5-methyl-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-82-2

β-D-allo-Octofuranoguanosine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-83-3

β-D-allo-Octofuranoguanosine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-84-4

β-D-allo-Octofuranoguanosine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-85-5

β-D-allo-Octofuranocytidine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-86-6

β-D-allo-Octofuranocytidine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1821057-87-7

β-D-allo-Octofuranocytidine, [P(S)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-[2-(methylamino)-2-oxoethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

1932713-02-4

β-D-allo-Octofuranoadenosine, [P(R)]-5′-O-[bis(4-methoxyphenyl)phenylmethyl]thymidylyl-(3′→5′-8′)-6′,7′,8′-trideoxy-2′-O-(2-methoxyethyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)

2005449-13-6

β-D-arabino-Adenosine, [P(R)]-2′-deoxy-2′-fluoro-P-thio-β-D-arabino-adenylyl-(3′→5′)-2′-deoxy-2′-fluoro-, 3′-[dihydrogen [P(R)]-phosphorothioate], cyclic nucleotide (ACI)

2005449-15-8

β-D-arabino-Adenosine, [P(R)]-2′-deoxy-2′-fluoro-P-thio-β-D-arabino-adenylyl-(3′→5′)-2′-deoxy-2′-fluoro-, 3′-[dihydrogen [P(S)]-phosphorothioate], cyclic nucleotide (ACI)

1093398-39-0

β-D-erythro-Hex-5-enofuranothymidine, [P(R)]-P-[5-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)pentyl]-5′-O-[(1,1-dimethylethyl)dimethylsilyl]thymidylyl-(3′→6′)-5′,6′-dideoxy-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite], (5′E)- (ACI)